Niki Karachaliou
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 46
- Oncology top 0.5%
- Lung Cancer Research Studies 50
- Cancer Immunotherapy and Biomarkers 31
- Colorectal Cancer Treatments and Studies 19
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations 129
- Lung Cancer Diagnosis and Treatment 13
- Molecular Biology top 2%
- Cancer therapeutics and mechanisms 21
-
- Cancer Mechanisms and Therapy 16
Niki Karachaliou
174 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Cancer Research 1.6k
- Oncology 2.9k
- Pulmonary and Respiratory Medicine 2.7k
- Molecular Biology 2.7k
- Pathology and Forensic Medicine 552
Countries citing papers authored by Niki Karachaliou
This map shows the geographic impact of Niki Karachaliou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niki Karachaliou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niki Karachaliou more than expected).
Fields of papers citing papers by Niki Karachaliou
This network shows the impact of papers produced by Niki Karachaliou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niki Karachaliou. The network helps show where Niki Karachaliou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Niki Karachaliou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 10 | |
| 4 | 2021 | 0 | |
| 5 | 2020 | 11 | |
| 6 | 2020 | 9 | |
| 7 | 2019 | 12 | |
| 8 | 2018 | 63 | |
| 9 | 2018 | 21 | |
| 10 | 2018 | 24 | |
| 11 | 2018 | 29 | |
| 12 | 2017 | 1 | |
| 13 | 2016 | 1 | |
| 14 | 2016 | 1 | |
| 15 | 2016 | 16 | |
| 16 | 2016 | 0 | |
| 17 | 2016 | 26 | |
| 18 | 2015 | 115 | |
| 19 | Targeting PD-1/PD-L1 in lung cancer: current perspectives | 2015 | 1 |
| 20 | 2014 | 180 |
About Niki Karachaliou
Niki Karachaliou is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 183 papers that have together received 5.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (129 papers), Lung Cancer Research Studies (50 papers), Cancer Genomics and Diagnostics (46 papers), Cancer Immunotherapy and Biomarkers (31 papers), Cancer therapeutics and mechanisms (21 papers), Colorectal Cancer Treatments and Studies (19 papers), Cancer Mechanisms and Therapy (16 papers) and Lung Cancer Diagnosis and Treatment (13 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.9k citations) and Pulmonary and Respiratory Medicine (2.7k citations). Niki Karachaliou has collaborated with scholars based in Spain, Italy and United States. Frequent co-authors include Rafael Rosell, Santiago Viteri, Miguel Ángel Molina‐Vila, Mariacarmela Santarpía, Ana Giménez‐Capitán, Trever G. Bivona, María González‐Cao, David P. Carbone, Cesare Gridelli and Tony Mok.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.